Gemcitabine, dexamethasone, cisplatin (GDP) salvage chemotherapy for relapsed or refractory Hodgkin's disease (HD): A National Cancer Institute of Canada Clinical Trials Group Study. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Crump, M
  • Baetz, T
  • Belch, A
  • Couban, S
  • Meyer, Ralph
  • Imrie, K
  • Yau, J
  • Myers, R
  • Paul, N
  • Turner, R
  • Shepherd, L
  • Iglesias, J

publication date

  • November 16, 2002

published in